NCT02022943 Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
| NCT ID | NCT02022943 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Banner Health |
| Condition | Alzheimer's Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 500,000 participants |
| Start Date | 2012-05 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500,000 participants in total. It began in 2012-05 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory \& thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit www.endALZnow.org
Eligibility Criteria
Inclusion Criteria: * Must be able to accept the Alzheimer's Prevention Registry website terms and conditions Exclusion Criteria: * None
Contact & Investigator
Jessica Langbaum, PhD
PRINCIPAL INVESTIGATOR
Banner Alzheimer's Institute
Frequently Asked Questions
Who can join the NCT02022943 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 110 Years, studying Alzheimer's Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02022943 currently recruiting?
Yes, NCT02022943 is actively recruiting participants. Contact the research team at info@endALZnow.org for enrollment information.
Where is the NCT02022943 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT02022943 clinical trial?
NCT02022943 is sponsored by Banner Health. The principal investigator is Jessica Langbaum, PhD at Banner Alzheimer's Institute. The trial plans to enroll 500,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.